Ab initio structure determination of phase II of racemic ibuprofen by X-ray powder diffraction

被引:47
作者
Derollez, Patrick [1 ]
Dudognon, Emeline [1 ]
Affouard, Frederic [1 ]
Danede, Florence [1 ]
Correia, Natalia T. [2 ]
Descamps, Marc [1 ]
机构
[1] Univ Lille 1, CNRS, Unite Mat & Transformat, UMR 8207, F-59655 Villeneuve Dascq, France
[2] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE, P-2829516 Caparica, Portugal
来源
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE | 2010年 / 66卷
关键词
ibuprofen; X-ray powder diffraction; rigid-body constraints; NEUTRON DIFFRACTION;
D O I
10.1107/S0108768109047363
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Annealing of the quenched ibuprofen at 258 K yielded a new crystalline form, called phase II. Powder X-ray diffraction patterns of this phase II were recorded with a laboratory diffractometer equipped with an INEL G3000 goniometer and a curved position-sensitive detector CPS120. The starting structural model was found by a Monte-Carlo simulated annealing method. The final structure was obtained through Rietveld refinements with rigid-body constraints for the phenyl group and soft restraints on the other interatomic bond lengths and bond angles. The cell volume is 5% larger than that of the conventional phase I at 258 K. It is also shown that the orientation of the propanoic acid group is drastically changed with respect to phase I, leading to strong modifications of the orientation of the O-H center dot center dot center dot O hydrogen bonds with respect to the chains of dimers. These structural considerations could explain the metastable character of this phase II.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [1] Ab initio structure determination of a new compound, β-SrGaBO4, from powder X-ray diffraction data
    Yang, Z
    Liang, JK
    Chen, XL
    Chen, JR
    JOURNAL OF SOLID STATE CHEMISTRY, 2002, 165 (01) : 119 - 124
  • [2] Copper(II)-hydroxo-oxoruthenate(VI):CuRuO2(OH)(4) - Ab initio structure determination by X-ray powder diffraction
    Hansen, T
    EUROPEAN POWDER DIFFRACTION: EPDIC IV, PTS 1 AND 2, 1996, 228 : 723 - 728
  • [3] Conformational analysis of an acyclic tetrapeptide: ab-initio structure determination from X-ray powder diffraction, Hirshfeld surface analysis and electronic structure
    Das, Uday
    Naskar, Jishu
    Mukherjee, Alok Kumar
    JOURNAL OF PEPTIDE SCIENCE, 2015, 21 (12) : 845 - 852
  • [4] Synthesis, spectroscopic studies and ab-initio structure determination from X-ray powder diffraction of bis-(N-3-acetophenylsalicylaidiminato)copper(II)
    Banerjee, S
    Mukherjee, AK
    Banerjee, I
    De, RL
    Neumann, MA
    Louer, D
    CRYSTAL RESEARCH AND TECHNOLOGY, 2005, 40 (08) : 815 - 821
  • [5] Simultaneous quantification of an enantiomer and the racemic compound of ibuprofen by X-ray powder diffractometry
    Phadnis, NV
    Suryanarayanan, R
    PHARMACEUTICAL RESEARCH, 1997, 14 (09) : 1176 - 1180
  • [6] Unknown crystal structure determination from X-ray powder diffraction data
    Ying Shi
    Jingkui Liang
    Quanlin Liu
    Xiaolong Chen
    Science in China Series A: Mathematics, 1998, 41 : 191 - 197
  • [7] Unknown crystal structure determination from X-ray powder diffraction data
    Shi, Y
    Liang, JK
    Liu, QL
    Chen, XL
    SCIENCE IN CHINA SERIES A-MATHEMATICS PHYSICS ASTRONOMY, 1998, 41 (02): : 191 - 197
  • [8] Unknown crystal structure determination from X-ray powder diffraction data
    施颖
    梁敬魁
    刘泉林
    陈小龙
    Science China Mathematics, 1998, (02) : 191 - 197
  • [9] Structure determination of the crystalline phase of n-butanol by powder X-ray diffraction and study of intermolecular associations by Raman spectroscopy
    Derollez, Patrick
    Hedoux, Alain
    Guinet, Yannick
    Danede, Florence
    Paccou, Laurent
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2013, 69 : 195 - 202
  • [10] Crystal structure determination of thymoquinone by high-resolution x-ray powder diffraction
    Pagola S.
    Benavente A.
    Raschi A.
    Romano E.
    Molina M.A.A.
    Stephens P.W.
    AAPS PharmSciTech, 5 (2)